文献速递关节外科

滑液α防御素与滑液C反应蛋白诊断假体周围关节感染的临床评价

Clinical Evaluation of Synovial Alpha Defensin and Synovial C-Reactive Protein in the Diagnosis of Periprosthetic Joint Infection.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

本研究回顾了183例接受假体周围关节感染评估患者的183次滑液α防御素和滑液C反应蛋白(CRP)检测,以肌肉骨骼感染学会(MSIS)标准为参照。α防御素单独检测灵敏度81.1%、特异度95.9%;α防御素与滑液CRP同时阳性时灵敏度73.0%、特异度99.3%;任一阳性时灵敏度91.9%、特异度79.5%。

要点

  • α防御素单独诊断假体周围关节感染的灵敏度为81.1%,特异度为95.9%。
  • α防御素与滑液CRP同时阳性时特异度达99.3%,灵敏度为73.0%。
  • 金属沉着症可致α防御素假阳性,低毒力微生物或引流窦道可致假阴性。

核心结论

  • α防御素联合滑液CRP对诊断假体周围关节感染表现出很高的灵敏度,但在金属沉着症存在时可能出现假阳性,在低毒力微生物存在时可能出现假阴性。
  • 当α防御素和滑液CRP两项检测均为阳性时,对诊断假体周围关节感染具有很高的特异度。

研究设计与样本

  • 回顾性分析了183例接受假体周围关节感染评估患者的183次滑液α防御素和滑液CRP检测,结果与肌肉骨骼感染学会(MSIS)标准进行比较。
  • 证据等级为诊断性研究III级。

主要发现

  • 在37例经MSIS标准诊断为感染的患者中,α防御素检测的灵敏度为81.1%(95%CI,64.8%至92.0%),特异度为95.9%(95%CI,91.3%至98.5%)。
  • α防御素检测有6例假阳性,其中4例与金属沉着症相关;有7例假阴性,其中3例与引流窦道相关,4例与低毒力微生物相关。
  • α防御素与滑液CRP同时阳性(n=28)时,灵敏度为73.0%(95%CI,55.9%至86.2%),特异度为99.3%(95%CI,96.2%至99.9%)。
  • α防御素或滑液CRP任一阳性(n=64)时,灵敏度为91.9%(95%CI,78.1%至98.3%),特异度为79.5%(95%CI,72.0%至85.7%)。

关键数值与推荐

  • 以MSIS标准为参考,α防御素单独检测灵敏度81.1%(95%CI,64.8%至92.0%),特异度95.9%(95%CI,91.3%至98.5%)。
  • α防御素与滑液CRP同时阳性时灵敏度73.0%(95%CI,55.9%至86.2%),特异度99.3%(95%CI,96.2%至99.9%)。
  • α防御素或滑液CRP任一阳性时灵敏度91.9%(95%CI,78.1%至98.3%),特异度79.5%(95%CI,72.0%至85.7%)。

临床怎么用

  • α防御素联合滑液CRP对诊断假体周围关节感染表现出很高的灵敏度,但金属沉着症存在时可能出现假阳性,低毒力微生物存在时可能出现假阴性。
  • 当α防御素和滑液CRP两项检测均为阳性时,对诊断假体周围关节感染具有很高的特异度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnosing periprosthetic joint infection after total joint arthroplasty is often challenging. The alpha defensin test has been recently reported as a promising diagnostic test for periprosthetic joint infection. The goal of this study was to determine the diagnostic accuracy of alpha defensin testing. METHODS: One hundred and eighty-three synovial alpha defensin and synovial fluid C-reactive protein (CRP) tests performed in 183 patients undergoing evaluation for periprosthetic joint infection were reviewed. Results were compared with the Musculoskeletal Infection Society (MSIS) criteria for periprosthetic joint infection. RESULTS: Alpha defensin tests were performed prior to surgical treatment for infection, and 37 of these patients who had these tests were diagnosed by MSIS criteria as having infections. Among this group, the alpha defensin test had a sensitivity of 81.1% (95% confidence interval [CI], 64.8% to 92.0%) and a specificity of 95.9% (95% CI, 91.3% to 98.5%). There were 6 false-positive results, 4 of which were associated with metallosis. There were 7 false negatives, all of which were associated with either draining sinuses (n = 3) or low-virulence organisms (n = 4). A combined analysis of alpha defensin and synovial fluid CRP tests was performed in which a positive result was represented by a positive alpha defensin test and a positive synovial fluid CRP test (n = 28). Among this group, the sensitivity was calculated to be 73.0% (95% CI, 55.9% to 86.2%) and the specificity was calculated to be 99.3% (95% CI, 96.2% to 99.9%). An additional combined analysis was performed where a positive result was represented by a positive alpha defensin test or positive synovial fluid CRP test (n = 64). Among this group, the sensitivity was calculated to be 91.9% (95% CI, 78.1% to 98.3%) and the specificity was calculated to be 79.5% (95% CI, 72.0% to 85.7%). CONCLUSIONS: Alpha defensin in combination with synovial fluid CRP demonstrates very high sensitivity for diagnosing periprosthetic joint infection, but may yield false-positive results in the presence of metallosis or false-negative results in the presence of low-virulence organisms. When both alpha defensin and synovial fluid CRP tests are positive, there is a very high specificity for diagnosing periprosthetic joint infection. LEVEL OF EVIDENCE: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Stone WZ, Gray CF, Parvataneni HK, et al. Clinical Evaluation of Synovial Alpha Defensin and Synovial C-Reactive Protein in the Diagnosis of Periprosthetic Joint Infection. J Bone Joint Surg Am. 2018. PMID: 30020121. doi:10.2106/JBJS.17.00556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。